Tag Archives: administrative hearing

DEA Prevails Over Masters Pharmaceutical, Inc.

On June 30, 2017, the Court of Appeals for the D.C. Circuit issued an order in Masters Pharmaceutical, Inc. v. Drug Enforcement Administration (No. 15-1335). In sum, the Court denied Masters Pharmaceutical, Inc.’s (“Masters”) Petition for Review seeking to overturn the Drug Enforcement Administration’s (“DEA”) revocation of Masters’ DEA registration. This decision has wide-ranging implications … Continue Reading

DEA Decisions: Evidence of “Red Flags” of Drug Diversion

On November 10, 2016, the DEA issued its final decision and order in the case against Jones Total Health Care Pharmacy, L.L.C. (“Jones Pharmacy”) and SND Health Care L.L.C. (“SND”). The Administrator ordered that the DEA deny Jones Pharmacy’s registration renewal application and also deny SND’s pending registration application. These orders were consistent with the … Continue Reading

DEA Decisions: In the Matter of The Medicine Shoppe

In the Matter of the Medicine Shoppe (October 2, 2014) DEA recently revoked the registration of the Medicine Shoppe, a San Antonio, Texas,  pharmacy, based on a finding that the pharmacy violated the Controlled Substances Act in all of the following ways: dispensed controlled substances without a prescription; dispensed controlled substances when the prescription was “signed” … Continue Reading

DEA Decisions: In the Matter of Moore Clinical Trials, L.L.C.

In the Matter of Moore Clinical Trials, L.L.C (July 11, 2014) DEA last month denied the DEA research registration application of an Arkansas clinical research company, finding that the person who would be primarily responsible for ordering and storing controlled substances had a “shocking” lack of knowledge of the fundamental requirements imposed by the Controlled … Continue Reading

DEA Decisions: In the Matter of Gabriel Sanchez

In the Matter of Gabriel Sanchez, M.D. (September 25, 2013) On July 15 2010, Dr. Gabriel Sanchez issued prescriptions for oxycodone (Schedule II) and carisoprodol (Schedule IV) to two undercover law enforcement officers.  During the visits with both undercover officers, Dr. Sanchez failed to take complete medical histories, failed to make serious inquiries into the … Continue Reading

DEA Decisions: In the Matter of S&S Pharmacy, Inc., d/b/a Platinum Pharmacy & Compounding

In the Matter of S&S Pharmacy, Inc., d/b/a Platinum Pharmacy & Compounding (Sept. 19, 2013) In 2011, Ihab S. Barsoum, the owner and pharmacist-in-charge of S&S Pharmacy, Inc., d/b/a Platinum Pharmacy & Compounding (“Platinum Pharmacy”), engaged in what the Administrator described as “blatant drug deal(s) and [] distribution(s).”  On five occasions between January and June … Continue Reading

DEA Decisions: In the Matter of Kevin Dennis, M.D.

In the Matter of Kevin Dennis, M.D. (August 26, 2013) In 2007, Dr. Kevin Dennis became involved with an Internet prescribing company known as “Telemed Ventures.”  Between 2007 and 2008, Dr. Dennis (who was licensed and registered in Tennessee only) issued numerous prescriptions to individuals located in other states without seeing them or performing any … Continue Reading

DEA Decisions: In the Matter of Mireille Lalanne

In the Matter of Mireille Lalanne, M.D., 78 Fed. Reg. 47,750 (August 6, 2013) Dr. Lalanne is a physician who, sometime before November 2008, became involved in an organized crime scheme.  Her role?  Dr. Lalanne provided controlled substance prescriptions to different syndicates for illegal distribution.  In November 2008, Dr. Lalanne was indicted by a Kentucky … Continue Reading
LexBlog